S. Murray Sherman to Biomarkers
This is a "connection" page, showing publications S. Murray Sherman has written about Biomarkers.
Connection Strength
0.110
-
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer. Clin Cancer Res. 2016 Jan 01; 22(1):44-53.
Score: 0.069
-
Evidence for nonreciprocal organization of the mouse auditory thalamocortical-corticothalamic projection systems. J Comp Neurol. 2008 Mar 10; 507(2):1209-27.
Score: 0.041